Following planning consent being granted for phase two of Granta Park, Eric Parry Architects is now developing detailed designs for the scheme.
Planning permission was given earlier this year by South Cambridgeshire District Council for the scheme, comprised of 368,000 sq ft of flexible lab and office space across five buildings on the park.
The new buildings will be part of a 28-acre extension of the park, originally masterplanned by Eric Parry Architects in the 1990s.
Developed with BioMed Realty, a Blackstone portfolio company, the designs will help meet the urgent demand for lab space in Cambridge in purpose-built accommodation designed specifically around the needs of post-startup / incubator biotech companies looking for space to scale their operations.
Phase two of Granta Park will deliver a 40 per cent biodiversity uplift across the site, with the new buildings achieving a 32 per cent improvement in energy efficiency over the building regulations, BREEAM Excellent, WiredScore and WELL Gold.
The buildings have been conceived as flexible lab and office buildings designed for both single occupiers and for multiple-lets to post-start-up / incubator life sciences businesses. The buildings facilitate the option to scale rapidly within a single building, with half-floorplates of 15,000 sq ft to meet the requirements of this group of users.
At present, Granta Park is home to 30 companies occupying 21 buildings within the park, with 3,700 employees involved in high-value research and development work for organisations that include Astra Zeneca, Pfizer, Gilead, and Cancer Research UK.
When complete, phase two will create space for an additional 2500 workers on site.
Image source: Eric Parry Architects
© Eastern Echo (powered by ukpropertyforums.com).
Sign up to receive your free bi-weekly Eastern Echo journal here.
